Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm.

Détails

Ressource 1Télécharger: Quah2020_Article_PrimaryGlomusTumourOfThePituit.pdf (3873.91 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_4715BD393409
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm.
Périodique
Virchows Archiv
Auteur⸱e⸱s
Quah B.L., Donofrio C.A., La Rosa S., Brouland J.P., Cossu G., Djoukhadar I., Mayers H., Shenjere P., Pereira M., Pathmanaban O.N., Murtaza M.O., Gattamaneni R., Roncaroli F., Karabatsou K.
ISSN
1432-2307 (Electronic)
ISSN-L
0945-6317
Statut éditorial
Publié
Date de publication
05/2021
Peer-reviewed
Oui
Volume
478
Numéro
5
Pages
977-984
Langue
anglais
Notes
Publication types: Case Reports
Publication Status: ppublish
Résumé
Primary non-neuroendocrine tumours of the pituitary gland and sella are rare lesions often challenging to diagnose. We describe two cases of clinically aggressive primary glomus tumour of the pituitary gland. The lesions occurred in a 63-year-old male and a 30-year-old female who presented with headache, blurred vision and hypopituitarism. Neuroimaging demonstrated large sellar and suprasellar tumours invading the surrounding structures. Histologically, the lesions were characterised by angiocentric sheets and nests of atypical cells that expressed vimentin, smooth muscle actin and CD34. Perivascular deposition of collagen IV was also a feature. Case 2 expressed synaptophysin. INI-1 (SMARCB1) expression was preserved. Both lesions were mitotically active and demonstrated a Ki-67 labelling index of 30%. Next-generation sequencing performed in case 1 showed no mutations in the reading frame of 37 commonly mutated oncogenes, including BRAF and KRAS. Four pituitary glomus tumours have previously been reported, none of which showed features of malignant glomus tumour. Similar to our two patients, three previous examples displayed aggressive behaviour.
Mots-clé
Adult, Biomarkers, Tumor/analysis, Biomarkers, Tumor/genetics, Diagnosis, Differential, Fatal Outcome, Female, Glomus Tumor/chemistry, Glomus Tumor/diagnostic imaging, Glomus Tumor/genetics, Glomus Tumor/pathology, High-Throughput Nucleotide Sequencing, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Invasiveness, Pituitary Neoplasms/chemistry, Pituitary Neoplasms/diagnostic imaging, Pituitary Neoplasms/genetics, Pituitary Neoplasms/pathology, Predictive Value of Tests, Glomus tumour, Malignant, Non-neuroendocrine tumour, Pituitary gland, Sella
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/09/2020 14:41
Dernière modification de la notice
21/11/2022 9:27
Données d'usage